(VIANEWS) – Chesapeake Granite Wash Trust (CHKR), Pimco Corporate & Income Strategy Fund (PCN), Manhattan Bridge Capital (LOAN) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Chesapeake Granite Wash Trust (CHKR) | 24.8% | 2023-06-23 23:48:08 |
| Pimco Corporate & Income Strategy Fund (PCN) | 10.41% | 2023-06-09 03:15:07 |
| Manhattan Bridge Capital (LOAN) | 9.26% | 2023-06-14 01:10:07 |
| AEGON N.V. (AEG) | 4.3% | 2023-06-23 04:41:08 |
| GlaxoSmithKline (GSK) | 3.95% | 2023-06-23 13:41:15 |
| Sapiens International Corporation N.V. (SPNS) | 3.5% | 2023-06-15 21:13:07 |
| Johnson & Johnson (JNJ) | 2.9% | 2023-06-23 13:42:01 |
| Value Line (VALU) | 2.41% | 2023-06-16 11:08:08 |
Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Chesapeake Granite Wash Trust (CHKR) – Dividend Yield: 24.8%
Chesapeake Granite Wash Trust’s last close was $1.13, 19.29% under its 52-week high of $1.40. Intraday change was -0.44%.
Chesapeake Granite Wash Trust owns royalty interests in oil, natural gas liquids, and natural gas properties located in the Colony Granite Wash play in Washita County in the Anadarko Basin of Western Oklahoma. The company has royalty interests in 69 producing wells and 118 development wells, and in approximately 26,400 net acres of area. As of December 31, 2020, its reserve estimates for the royalty interests included 2,736 thousand barrels of oil equivalent of proved developed reserves. Chesapeake Granite Wash Trust was founded in 2011 and is based in Houston, Texas.
Earnings Per Share
As for profitability, Chesapeake Granite Wash Trust has a trailing twelve months EPS of $0.29.
PE Ratio
Chesapeake Granite Wash Trust has a trailing twelve months price to earnings ratio of 3.9. Meaning, the purchaser of the share is investing $3.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 124.33%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 18, 2023, the estimated forward annual dividend rate is 0.28 and the estimated forward annual dividend yield is 24.8%.
Moving Average
Chesapeake Granite Wash Trust’s value is under its 50-day moving average of $1.17 and under its 200-day moving average of $1.18.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.9%, now sitting on 15M for the twelve trailing months.
Yearly Top and Bottom Value
Chesapeake Granite Wash Trust’s stock is valued at $1.13 at 03:15 EST, way under its 52-week high of $1.40 and way higher than its 52-week low of $0.90.
More news about Chesapeake Granite Wash Trust.
2. Pimco Corporate & Income Strategy Fund (PCN) – Dividend Yield: 10.41%
Pimco Corporate & Income Strategy Fund’s last close was $12.97, 11.04% below its 52-week high of $14.58. Intraday change was 0%.
PIMCO Corporate & Income Strategy Fund is a closed-ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Pacific Investment Management Company LLC. It invests in the fixed income markets of the United States. The fund invests in securities of companies that operate across diversified sectors. It invests in fixed income securities such as treasury bonds, corporate notes, U.S. government agency securities, mortgage backed and asset-backed securities. The fund employs fundamental analysis with a top-down security selection process to create its portfolio. The fund was formerly known as PIMCO Corporate Income Fund. PIMCO Corporate & Income Strategy Fund was formed on October 17, 2001 and is domiciled in the United States.
Earnings Per Share
As for profitability, Pimco Corporate & Income Strategy Fund has a trailing twelve months EPS of $0.84.
PE Ratio
Pimco Corporate & Income Strategy Fund has a trailing twelve months price to earnings ratio of 15.44. Meaning, the purchaser of the share is investing $15.44 for every dollar of annual earnings.
More news about Pimco Corporate & Income Strategy Fund.
3. Manhattan Bridge Capital (LOAN) – Dividend Yield: 9.26%
Manhattan Bridge Capital’s last close was $4.93, 19.71% below its 52-week high of $6.14. Intraday change was -2.76%.
Manhattan Bridge Capital, Inc., a real estate finance company, originates, services, and manages a portfolio of first mortgage loans in the United States. It offers short-term, secured, and non-banking loans to real estate investors to fund their acquisition, renovation, rehabilitation, or enhancement of properties in the New York metropolitan area, including New Jersey and Connecticut, and in Florida. The company's loans are primarily secured by collateral consisting of real estate and accompanied by personal guarantees from the principals of the borrowers. It qualifies as a real estate investment trust for federal income tax purposes. The company generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. Manhattan Bridge Capital, Inc. was founded in 1989 and is headquartered in Great Neck, New York.
Earnings Per Share
As for profitability, Manhattan Bridge Capital has a trailing twelve months EPS of $0.44.
PE Ratio
Manhattan Bridge Capital has a trailing twelve months price to earnings ratio of 11.2. Meaning, the purchaser of the share is investing $11.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.71%.
Yearly Top and Bottom Value
Manhattan Bridge Capital’s stock is valued at $4.93 at 03:15 EST, way under its 52-week high of $6.14 and above its 52-week low of $4.61.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 8.3% and positive 9.1% for the next.
More news about Manhattan Bridge Capital.
4. AEGON N.V. (AEG) – Dividend Yield: 4.3%
AEGON N.V.’s last close was $4.79, 15.82% below its 52-week high of $5.69. Intraday change was 0.21%.
Aegon N.V. provides insurance, pensions, and asset management services in the Americas, Europe, and Asia. Its insurance products include life, accident, and health insurance; property and casualty insurance; and household and car insurance. The company also offers savings products, such as retirement plan services; annuities; mutual funds; and stable value solutions. In addition, it provides retail and institutional investment management solutions, retirement savings vehicles, residential mortgages, and digital banking services. The company markets its products through brokers, agents, banks, employee benefit consultants, independent financial advisors, bancassurance channels, and advice centers. Aegon N.V. was founded in 1983 and is headquartered in The Hague, the Netherlands.
Earnings Per Share
As for profitability, AEGON N.V. has a trailing twelve months EPS of $-0.47.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.07%.
Moving Average
AEGON N.V.’s worth is higher than its 50-day moving average of $4.56 and above its 200-day moving average of $4.72.
Volume
Today’s last reported volume for AEGON N.V. is 1358860 which is 19.23% below its average volume of 1682380.
Yearly Top and Bottom Value
AEGON N.V.’s stock is valued at $4.79 at 03:15 EST, way under its 52-week high of $5.69 and way higher than its 52-week low of $3.76.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Aug 22, 2022, the estimated forward annual dividend rate is 0.21 and the estimated forward annual dividend yield is 4.3%.
More news about AEGON N.V..
5. GlaxoSmithKline (GSK) – Dividend Yield: 3.95%
GlaxoSmithKline’s last close was $36.38, 18.7% under its 52-week high of $44.75. Intraday change was 4.93%.
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
Earnings Per Share
As for profitability, GlaxoSmithKline has a trailing twelve months EPS of $2.79.
PE Ratio
GlaxoSmithKline has a trailing twelve months price to earnings ratio of 13.04. Meaning, the purchaser of the share is investing $13.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.17%.
Volume
Today’s last reported volume for GlaxoSmithKline is 5761140 which is 92.75% above its average volume of 2988840.
More news about GlaxoSmithKline.
6. Sapiens International Corporation N.V. (SPNS) – Dividend Yield: 3.5%
Sapiens International Corporation N.V.’s last close was $27.14, 0.73% below its 52-week high of $27.34. Intraday change was 0.07%.
Sapiens International Corporation N.V. provides software solutions for the insurance and financial services industries in North America, Europe, the Asia Pacific, and South Africa. The company offers Sapiens CoreSuite and Sapiens IDITSuite for personal, commercial, and specialty lines, as well as reinsurance and workers' compensation; and Sapiens CoreSuite, Sapiens UnderwritingPro, Sapiens ApplicationPro, Sapiens IllustrationPro, and Sapiens ConsolidationMaster for life, pension, and annuities. It also provides Sapiens DigitalSuite for insurance customers, agents, brokers, risk managers, customer groups and third-party service providers; Sapiens AgentConnect and Sapiens CustomerConnect portals; Sapiens Intelligence, an analytics platform; Sapiens IntelligencePro, a comprehensive BI solution with pre-configured reports, dashboards, and scorecards; and Sapiens Advanced Analytics, which uses AI and Machine Learning to generate actionable insights based on different models across the insurance value chain. In addition, the company offers Sapiens ReinsuranceMaster, Sapiens ReinsurancePro, and Sapiens Reinsurance GO reinsurance solutions; and Sapiens Platform, Sapiens CoreSuite, Sapiens PolicyPro, and Sapiens ClaimsPro, as well as Sapiens PolicyGo, Sapiens ClaimsGo, and Sapiens Connect for workers' compensation. Further, it provides financial and compliance solutions, which comprise Sapiens FinancialPro, Sapiens Financial GO, Sapiens StatementPro, Sapiens CheckPro, and Sapiens Reporting Tools; and Sapiens Decision, an enterprise-scale platform that enables institutions to centrally author, store, and manage various organizational business logics. Additionally, the company offers tailor-made solutions based on its Sapiens eMerge platform; and program delivery, business, and managed services. It markets and sells its products and services through direct and partner sales. The company was founded in 1982 and is headquartered in Holon, Israel.
Earnings Per Share
As for profitability, Sapiens International Corporation N.V. has a trailing twelve months EPS of $0.96.
PE Ratio
Sapiens International Corporation N.V. has a trailing twelve months price to earnings ratio of 28.27. Meaning, the purchaser of the share is investing $28.27 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.76%.
Yearly Top and Bottom Value
Sapiens International Corporation N.V.’s stock is valued at $27.14 at 03:15 EST, below its 52-week high of $27.34 and way higher than its 52-week low of $16.18.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6%, now sitting on 481.76M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Sapiens International Corporation N.V.’s EBITDA is 2.92.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 18.5% and 10%, respectively.
More news about Sapiens International Corporation N.V..
7. Johnson & Johnson (JNJ) – Dividend Yield: 2.9%
Johnson & Johnson’s last close was $165.48, 9.75% under its 52-week high of $183.35. Intraday change was -0.28%.
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Earnings Per Share
As for profitability, Johnson & Johnson has a trailing twelve months EPS of $4.77.
PE Ratio
Johnson & Johnson has a trailing twelve months price to earnings ratio of 34.62. Meaning, the purchaser of the share is investing $34.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.48%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 21, 2023, the estimated forward annual dividend rate is 4.76 and the estimated forward annual dividend yield is 2.9%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Johnson & Johnson’s EBITDA is 4.73.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Johnson & Johnson’s stock is considered to be oversold (<=20).
More news about Johnson & Johnson.
8. Value Line (VALU) – Dividend Yield: 2.41%
Value Line’s last close was $46.00, 61.15% below its 52-week high of $118.40. Intraday change was -1.48%.
Value Line, Inc., together with its subsidiaries, produces and sells investment periodicals and related publications primarily in the United States. Its investment periodicals and related publications cover a range of investments, including stocks, mutual funds, exchange traded funds (ETFs), and options. The company offers research services, such as The Value Line Investment Survey, The Value Line Investment Survey – Small and Mid-Cap, The Value Line 600, and The Value Line Fund Advisor Plus, which provide statistical and text coverage of various investment securities, with an emphasis placed on its proprietary research, analysis, and statistical ranks. It also provides niche newsletters comprising Value Line Select, Value Line Select: Dividend Income & Growth, Value Line Select: ETFs, and The Value Line Special Situations Service that offer information on a less comprehensive basis for securities that are of particular interest to subscribers; digital versions of its products through its Website, www.valueline.com, as well as The Value Line Research Center online platform; and investment analysis software, such as The Value Line Investment Analyzer, which includes data sorting and filtering tools. In addition, the company offers current and historical financial databases comprising DataFile, estimates and projections, and mutual funds through the Internet; investment analysis software; and copyright products, which include unit investment trusts, variable annuities, managed accounts, and EFTs. Further, it places advertising on behalf of the company's publications; and provides subscription fulfillment and subscriber relation services. The company serves individual and professional investors, as well as institutions, including municipal and university libraries, and investment firms. Value Line, Inc. was founded in 1931 and is headquartered in New York, New York. Value Line, Inc. is a subsidiary of Arnold Bernhard & Co, Inc.
Earnings Per Share
As for profitability, Value Line has a trailing twelve months EPS of $1.88.
PE Ratio
Value Line has a trailing twelve months price to earnings ratio of 24.11. Meaning, the purchaser of the share is investing $24.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.08%.
Yearly Top and Bottom Value
Value Line’s stock is valued at $45.32 at 03:15 EST, way below its 52-week high of $118.40 and above its 52-week low of $42.02.
Moving Average
Value Line’s value is under its 50-day moving average of $47.10 and way under its 200-day moving average of $53.04.
More news about Value Line.
